Karyotype analysis in chronic myelogenous leukemia. A three-year experience at the American University of Beirut Medical Center (AUBMC)

J Med Liban. 1998 Jan-Feb;46(1):16-9.

Abstract

We report the results of karyotype analysis on cases referred to our laboratory for chronic myelogenous leukemia (CML) over a period of three years. A total of 68 patient were referred and a karyotype was successfully obtained in all cases except one. Thirty-one percent of cases were found to have a normal karyotype, 58.5% were Philadelphia (Ph1) positive while 10.5% of cases had chromosome abnormalities other than Ph1. Among the Ph1 positive cases, 92% had the standard translocation (9;22), 7.7% had a variant translocation and 12.8% had additional chromosome abnormalities. Our results are compared to those generally reported in the literature and the comparisons are discussed.

MeSH terms

  • Adult
  • Chromosome Aberrations / diagnosis
  • Chromosome Aberrations / genetics*
  • Chromosome Disorders
  • Female
  • Hospitals, University
  • Humans
  • Karyotyping
  • Lebanon
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / diagnosis
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / genetics*
  • Male
  • Referral and Consultation
  • Translocation, Genetic